A Q1 2024 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B-5.6% YoY

Gross Profit

$908M54.8% margin

Operating Income

$384M23.2% margin

Net Income

$348M21.0% margin

EPS (Diluted)

$1.18

QoQ Revenue Growth

-1.8%

Cash Flow

Operating Cash Flow

$485M

Free Cash Flow

$395M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$10.9B

Total Liabilities

$4.8B

Stockholders' Equity

$6.2B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.8B	-5.6%
Gross Profit	$908M	$968M	-6.2%
Operating Income	$384M	$426M	-9.9%
Net Income	$348M	$352M	-1.1%

Revenue Segments

Life Sciences and Applied Markets

$846M51%

Diagnostics and Genomics

$407M25%

Agilent CrossLab

$405M24%

Geographic Segments

Americas

$630M38%

Asia Pacific

$570M34%

Europe

$458M28%